Actinium Pharmaceuticals Inc Revenue per Employee (ATNM), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Actinium Pharmaceuticals Inc  (NYSE: ATNM)
 

Actinium Pharmaceuticals Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Actinium Pharmaceuticals Inc's Revenue per employee fell on a trailing twelve month basis to $ 1,403,600, below the company average number of $49,000.
Within the Healthcare sector Actinium Pharmaceuticals Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Actinium Pharmaceuticals Inc has 25 employees.


What is Sales per Employee Ratio?







ATNM Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
2026
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 1,403,600 3,600 3,600 3,600 -
ATNM's Total Ranking # # # # #
Seq. Revenue Change - - - - -


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 58,480 $ 49,000 $ 42,120
(Mar 31 2022)   (Sep 30 2022)



Financial Statements
Actinium Pharmaceuticals Inc's Revenue MRQ $ 35 Millions Visit ATNM's Income Statement
Actinium Pharmaceuticals Inc's Revenues TTM $ 35 Millions Visit ATNM's aggregate revenue growth
What are ATNM's Sales? Visit ATNM's Sales by Segment




Other Ratios
Actinium Pharmaceuticals Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ATNM's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ATNM's Competitors
Revenue per Employee for ATNM's Suppliers
Revenue per Employee for ATNM's Customers

You may also want to know
ATNM's Sales Growth Rates ATNM's Pe Price to earnings ratio ATNM's Receivables Turnover Ratio ATNM's Stock Quote
ATNM's Net Income Growth Rates ATNM's Ps Price to Sales ratio ATNM's Sales per Employee ATNM's Asset Turnover Ratio
ATNM's Net Margin ATNM's Pb Price to Book ratio ATNM's Financial Strength Ratios ATNM's Dividend Payout Ratio
Date modified: 2026-08-14T13:00:53+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Sarepta Therapeutics Inc   2,364,483.83 $ 1,974.344  Million 835 
United Therapeutics Corporation  2,253,214.29 $ 3,154.500  Million 1,400 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Protagonist Therapeutics inc   2,136,303.03 $ 281.992  Million 132 
Exelixis Inc   2,123,731.47 $ 2,435.920  Million 1,147 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Alnylam Pharmaceuticals Inc   1,921,672.80 $ 4,804.182  Million 2,500 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Eli Lilly And Company  1,593,316.00 $ 79,665.800  Million 50,000 
Jazz Pharmaceuticals Plc  1,592,122.15 $ 4,601.233  Million 2,890 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Bristol myers Squibb Company  1,513,415.38 $ 49,186.000  Million 32,500 
Krystal Biotech Inc   1,493,166.10 $ 440.484  Million 295 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.